T. Rowe Price Associates
NUS icon

T. Rowe Price Associates’s Nu Skin NUS Stock Holding History

T. Rowe Price Associates’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$508K Buy
69,693
+5,712
+9% +$51.7K ﹤0.01% 2452
2025
Q4 		$616K Sell
63,981
-2,835
-4% -$29.3K ﹤0.01% 2297
2025
Q3 		$815K Buy
66,816
+2,810
+4% +$29.5K ﹤0.01% 2150
2025
Q2 		$512K Buy
64,006
+1,313
+2% +$9.22K ﹤0.01% 2289
2025
Q1 		$456K Buy
62,693
+8,982
+17% +$65.3K ﹤0.01% 2284
2024
Q4 		$371K Buy
53,711
+2,702
+5% +$18.6K ﹤0.01% 2413
2024
Q3 		$376K Buy
51,009
+4,400
+9% +$41.1K ﹤0.01% 2375
2024
Q2 		$492K Buy
46,609
+1,453
+3% +$18.4K ﹤0.01% 2193
2024
Q1 		$625K Buy
45,156
+6,502
+17% +$102K ﹤0.01% 2119
2023
Q4 		$751K Buy
38,654
+11,904
+45% +$220K ﹤0.01% 2001
2023
Q3 		$568K Buy
26,750
+2,357
+10% +$61.3K ﹤0.01% 2045
2023
Q2 		$810K Buy
24,393
+1,107
+5% +$40.8K ﹤0.01% 1907
2023
Q1 		$916K Sell
23,286
-779
-3% -$32.4K ﹤0.01% 1832
2022
Q4 		$1.01M Buy
24,065
+618
+3% +$23.8K ﹤0.01% 1766
2022
Q3 		$783K Buy
23,447
+3,242
+16% +$135K ﹤0.01% 1883
2022
Q2 		$875K Buy
20,205
+292
+1% +$13.4K ﹤0.01% 1961
2022
Q1 		$953K Buy
19,913
+3,393
+21% +$168K ﹤0.01% 2028
2021
Q4 		$838K Sell
16,520
-787
-5% -$35K ﹤0.01% 2115
2021
Q3 		$700K Buy
17,307
+36
+0.2% +$1.82K ﹤0.01% 2216
2021
Q2 		$978K Buy
17,271
+277
+2% +$15.8K ﹤0.01% 2078
2021
Q1 		$899K Buy
16,994
+316
+2% +$17.2K ﹤0.01% 2108
2020
Q4 		$911K Buy
16,678
+5,394
+48% +$284K ﹤0.01% 1990
2020
Q3 		$565K Sell
11,284
-57
-0.5% -$2.7K ﹤0.01% 2038
2020
Q2 		$434K Sell
11,341
-15,207
-57% -$489K ﹤0.01% 2102
2020
Q1 		$580K Buy
26,548
+7,330
+38% +$221K ﹤0.01% 1913
2019
Q4 		$788K Sell
19,218
-183,215
-91% -$7.48M ﹤0.01% 1989
2019
Q3 		$8.61M Sell
202,433
-1,272
-0.6% -$53.4K ﹤0.01% 1314
2019
Q2 		$10M Sell
203,705
-50
-0% -$2.54K ﹤0.01% 1316
2019
Q1 		$9.75M Sell
203,755
-93,820
-32% -$5.69M ﹤0.01% 1328
2018
Q4 		$18.3M Buy
297,575
+212
+0.1% +$14.3K ﹤0.01% 1171
2018
Q3 		$24.5M Buy
297,363
+13,138
+5% +$1.04M ﹤0.01% 1160
2018
Q2 		$22.2M Buy
284,225
+20,257
+8% +$1.57M ﹤0.01% 1171
2018
Q1 		$19.5M Buy
263,968
+17,564
+7% +$1.25M ﹤0.01% 1194
2017
Q4 		$16.8M Buy
246,404
+1,653
+0.7% +$107K ﹤0.01% 1242
2017
Q3 		$15M Buy
244,751
+15,177
+7% +$932K ﹤0.01% 1266
2017
Q2 		$14.4M Buy
229,574
+15,832
+7% +$902K ﹤0.01% 1253
2017
Q1 		$11.9M Buy
213,742
+15,433
+8% +$795K ﹤0.01% 1299
2016
Q4 		$9.47M Buy
198,309
+23,204
+13% +$1.3M ﹤0.01% 1329
2016
Q3 		$11.3M Buy
175,105
+48,300
+38% +$2.72M ﹤0.01% 1288
2016
Q2 		$5.86M Buy
126,805
+882
+0.7% +$35.5K ﹤0.01% 1377
2016
Q1 		$4.82M Sell
125,923
-11,000
-8% -$364K ﹤0.01% 1405
2015
Q4 		$5.19M Sell
136,923
-14,817
-10% -$546K ﹤0.01% 1410
2015
Q3 		$6.26M Sell
151,740
-4,862
-3% -$209K ﹤0.01% 1403
2015
Q2 		$7.38M Buy
156,602
+15,755
+11% +$852K ﹤0.01% 1413
2015
Q1 		$8.48M Sell
140,847
-14,190
-9% -$722K ﹤0.01% 1376
2014
Q4 		$6.78M Sell
155,037
-12,950
-8% -$572K ﹤0.01% 1417
2014
Q3 		$7.56M Sell
167,987
-22,876
-12% -$1.22M ﹤0.01% 1375
2014
Q2 		$14.1M Buy
190,863
+12,621
+7% +$995K ﹤0.01% 1227
2014
Q1 		$14.8M Buy
178,242
+542
+0.3% +$47.6K ﹤0.01% 1192
2013
Q4 		$24.6M Buy
177,700
+4,900
+3% +$577K 0.01% 1040
2013
Q3 		$16.5M Buy
172,800
+14,200
+9% +$1.21M ﹤0.01% 1139
2013
Q2 		$9.69M Buy
+158,600
New +$8.8M ﹤0.01% 1258

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

T. Rowe Price Associates's NUS Position: Q1 2026 in Review

T. Rowe Price Associates increased its Nu Skin (NUS) stake by 8.9% in Q1 2026, buying an estimated $51.7K and bringing the position to 69,693 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #2452.

T. Rowe Price Associates first reported a position in NUS in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.6M in Q4 2013. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • T. Rowe Price Associates held 69,693 shares of Nu Skin worth $508K as of Q1 2026.
  • T. Rowe Price Associates bought 5,712 Nu Skin shares in Q1 2026, an estimated $51.7K.
  • Nu Skin made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2452 holding.
  • T. Rowe Price Associates first reported a position in Nu Skin in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Nu Skin position peaked at $24.6M in Q4 2013.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.